Oil prices declined on Monday, extending the losses sustained last week after the resurgent of the coronavirus pandemic in the U.S. and Europe and Libya’s growing production, according to Reuters.…
Bayer AG will acquire Asklepios BioPharmaceutical Inc. (AskBio), a U.S. biotech firm, for $4 billion as the German pharmaceutical and chemical market bets on gene therapy, according to the company's…
The U.S. economy has started Q4 solidly as private sector business activity in September grew to a rate not seen since early 2019 despite being weaker than August level, according…
Have you been thinking about diversifying to ensure passive sources of income? Are you hoping to put away your cash and thrash the rising swelling in the economy? Derivatives have…
The U.S. Food and Drug Administration (FDA) has approved Gilead Sciences Inc.’s Veklury (remdesivir), an antiviral drug for the treatment of patients with COVID19 requiring hospitalization, according to the company’s…
The U.S. final presidential debate held in Nashville, Tennessee on Thursday evening saw Trump and Biden raise key points to woe undecided American voters, according to Reuters. Here are the…
Barclays Group Q3 2020 income was £5.2 billion, down 6% from the prior year, according to the company’s press release. Earnings per share (EPS) is 7.6 pence down from Q3…
Apple’s recently launched iPhone 12 line is showing strong demand in China, more than last year’s iPhone 11, according to SCMP. China accounts for 35% to 45% of global demand…
Hong Kong’s Securities and Futures Commission (SFC) on Thursday fined Goldman Sachs a record $350 million for its involvement in Malaysia’s multibillion-dollar IMDB scandal, according to Reuters. Goldman Sachs (Asia)…
Sukhoi Log, located in the Irkutsk region of Siberia, has 40 million ounces of proven reserves with an average gold content of 2.3 grams per ton, according to Bloomberg. The…
U.S. initial jobless claims in the week ending October 17 were 787,000, a decline of 55,000 from the previous week’s revised level and down from expected 870,000, according to a…
Traders are worried that complacency over the coronavirus vaccine could affect markets, according to CNBC. Five vaccines, from Moderna, AstraZeneca, Pfizer, Johnson & Johnson, and Novavax are in phase 3…